NovaBay Pharmaceuticals Spotlights NeutroPhase(R) at the Symposium on Advanced Wound Care (SAWC) – msnbc.com

Oct. 14, 2011 (GLOBE NEWSWIRE) — NovaBay Pharmaceuticals, Inc. (NYSE Amex:NBY), a clinical-stage biotechnology company developing non-antibiotic anti-infective agents for topical non-systemic applications, today announced the first introduction …